Journal of the Korean Ophthalmological Society 2006;47(6):971-976.
Published online June 30, 2006.
Effects of Neodymium:YAG Laser and Tissue Plasminogen Activator on Massive Diabetic Premacular Hemorrhage.
Young Hoon Park, Won Ki Lee, Jin Chung, Hyun Seung Kim, Young Chun Lee
1Department of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea. leeyc@cmc.cuk.ac.kr
2St. Mary's Eye Clinic, Uijeongbu, Korea.
다량의 당뇨성 황반전출혈에 대한 야그레이저와 조직형플라스미노젠 활성제의 병합치료 효과
박영훈1,이원기1,정진2,김현승1,이영춘1
Department of Ophthalmology, College of Medicine, The Catholic University of Korea1, Seoul, Korea, St. Mary??s Eye Clinic2, Uijeongbu, Korea
Correspondence:  Young Hoon Park, M.D.1
Abstract
PURPOSE
To investigate the combined therapeutic effects of Neodymium:YAG (Nd:YAG) laser membranotomy and intravitreal tissue plasminogen activator (tPA) on massive diabetic premacular hemorrhage. METHODS: The authors performed Nd:YAG laser membranotomy on the hemorrhagic membrane of premacular hemorrhages and injected tPA (25 microgram) into the vitreous cavity of 5 eyes with massive diabetic premacular hemorrhage. Each time, 0.2 ml of perfluoropropane (C3F8) gas was also injected. RESULTS: After Nd:YAG laser membranotomy and tPA injection, the patients' vision recovered within 4 weeks and the hemorrhages were completely absorbed within 8 weeks. Visual acuity at the last visit had improved to a mean of 10 lines (8-13 lines) on ETDRS charts for all cases. There were no associated ophthalmic complications. Also, there were no cases that required vitrectomy. CONCLUSIONS: Combined therapy of Nd:YAG laser membranotomy and tPA injection with an expansive gas is a good alternative method to observation or simple Nd:YAG laser treatment for resolution of premacular hemorrhages in proliferative diabetic retinopathy patients, and may allow for faster resolution of hemorrhages without the complications of vitrectomy.
Key Words: Nd:YAG laser;Premacular hemorrhage;Tissue plasminogen activator


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next